Back
Stellantis NV Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
28
STLA
Stellantis NV
Last Price:
$9.42
Seasonality Move:
-1.15%
Sell
36
CRSP
CRISPR Therapeutics AG
Last Price:
$38.28
Seasonality Move:
20.1%
Sell
28
Stellantis NV (STLA)
is a Sell
Is Stellantis NV a Buy, Sell or Hold?
-
The current Stellantis NV [STLA] share price is $9.33. The Score for STLA is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
STLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $39.11. The Score for CRSP is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
STLA Stock Price Chart
What is Stellantis NV's stock price today?
-
The Stellantis NV share price today is $9.33Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STLA is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $39.11The current trend is moderately bullish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
STLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.73 | Sell |
Relative Strength Index (14 RSI): | 40.78 | Sell |
Chaikin Money Flow: | 10444644 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.04 - 11.58) | Sell |
Bollinger Bands (100): | (10.94 - 13.78) | Sell |
CRSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.38 | Buy |
Relative Strength Index (14 RSI): | 53.36 | Buy |
Chaikin Money Flow: | 1012410 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.92 - 40.24) | Buy |
Bollinger Bands (100): | (37.28 - 47) | Sell |
STLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.3 | Buy |
20-day SMA: | 9.84 | Sell |
50-day SMA: | 11.65 | Sell |
200-day SMA: | 13.96 | Sell |
8-day EMA: | 9.32 | Buy |
20-day EMA: | 9.91 | Sell |
50-day EMA: | 11.1 | Sell |
200-day EMA: | 14.11 | Sell |
CRSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.5 | Buy |
20-day SMA: | 36.09 | Buy |
50-day SMA: | 40.73 | Sell |
200-day SMA: | 45.9 | Sell |
8-day EMA: | 38.08 | Buy |
20-day EMA: | 34.24 | Buy |
50-day EMA: | 23.43 | Buy |
200-day EMA: | 8.2 | Buy |
Stellantis NV Earnings Growth & STLA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $1.15 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.04 per share, an increase this year of $0.12 per share, and an increase next year of $0.94 per share.
Stellantis NV Technical Analysis
Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
10 | 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CRISPR Therapeutics AG Technical Analysis
Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
10 | 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |